Developing Value Propositions that Optimize Brand Access for Leading Payers
Leading payers pursue strategies that evolve their business models, and approaches to care and drug management, such as clinical innovation, Medicare growth and more. Biopharma must understand the implications of these strategies to develop differentiated value propositions that optimize brand access.
A full report with additional insights is available as part of the NAVLIN Insights subscription. Contact us at [email protected] for access and to learn more about NAVLIN by EVERSANA and our innovative market research solutions.